Drug
Dalbavancin
Dalbavancin: highest development phase Approved, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| DALBAVANCIN | Approved |
Latest
No recent events.
Follow Dalbavancin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.